The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial
Miao Liu,1– 3 Yuan Sun,1– 3 Lingxue Zhou,1– 3 Kunpeng Feng,1– 3 Tianlong Wang,1– 3 Xuexin Feng1– 3 1Department of Anesthesiology, Capital Medical University Xuanwu Hospital, Beijing, People’s Republic of China; 2Center for Sleep and Consciousness Disorders, Capital Medical University, Beijing, Peopl...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-05-01
|
| Series: | Clinical Interventions in Aging |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-median-effective-dose-and-bispectral-index-of-remimazolam-tosilate-peer-reviewed-fulltext-article-CIA |
| _version_ | 1817981008406904832 |
|---|---|
| author | Liu M Sun Y Zhou L Feng K Tianlong Wang Feng X |
| author_facet | Liu M Sun Y Zhou L Feng K Tianlong Wang Feng X |
| author_sort | Liu M |
| collection | DOAJ |
| description | Miao Liu,1– 3 Yuan Sun,1– 3 Lingxue Zhou,1– 3 Kunpeng Feng,1– 3 Tianlong Wang,1– 3 Xuexin Feng1– 3 1Department of Anesthesiology, Capital Medical University Xuanwu Hospital, Beijing, People’s Republic of China; 2Center for Sleep and Consciousness Disorders, Capital Medical University, Beijing, People’s Republic of China; 3Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Xuexin Feng, Department of Anesthesiology, Capital Medical University Xuanwu Hospital, No. 45 Changchun St., Xicheng District, Beijing, 100053, People’s Republic of China, Tel +86-1083798277, Email fengxuexin@xwhosp.orgPurpose: Remimazolam is a new type of ultrashort benzodiazepine drug with an unclear optimal dose for general anesthesia induction in elderly patients aged > 60 years. Therefore, this study aimed to determine the effective dose of remimazolam tosilate induction and explore its correlation with the bispectral index (BIS).Patients and Methods: A total of 42 elderly patients were divided into two age groups: 60– 69 (group A) and 70– 85 (group B) years. An initial dose of 0.1mg/kg(Group A) and 0.05 mg/kg(Group B) remimazolam tosilate was administered, and the Modified Observer’s Assessment of Alertness/Sedation scale was used to assess adequate responses. The dose was calculated using the up-and-down allocation technique based on the previous response. The sequential formula and probit regression model were used to calculate ED50 and BIS50. ED95 was determined using the probit regression model.Results: The ED50 of remimazolam tosilate for anesthesia induction were 0.088 mg/kg (95% confidence interval [CI] 0.071– 0.108) and 0.061 mg/kg (95% CI 0.053– 0.069) in groups A and B, respectively. ED95 was 0.118 mg/kg (95% CI 0.103– 0.649) and 0.090 mg/kg (95% CI 0.075– 0.199) in groups A and B, respectively. The remimazolam tosilate administration could decrease BIS. BIS50 was 86.0 (95% CI 83.7– 88.6) and 85.4 (95% CI 84.1– 86.8) in groups A and B, respectively.Conclusion: During the induction process, patients’ consciousness should be observed. The dose of remimazolam tosilate could be chosen after careful consideration of individual variations.Keywords: remimazolam, anesthesia induction, geriatric, up-and-down sequential allocation |
| first_indexed | 2024-04-13T23:01:23Z |
| format | Article |
| id | doaj.art-faca7787aa714db689baeedfd0411a9d |
| institution | Directory Open Access Journal |
| issn | 1178-1998 |
| language | English |
| last_indexed | 2024-04-13T23:01:23Z |
| publishDate | 2022-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical Interventions in Aging |
| spelling | doaj.art-faca7787aa714db689baeedfd0411a9d2022-12-22T02:25:51ZengDove Medical PressClinical Interventions in Aging1178-19982022-05-01Volume 1783784375416The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation TrialLiu MSun YZhou LFeng KTianlong WangFeng XMiao Liu,1– 3 Yuan Sun,1– 3 Lingxue Zhou,1– 3 Kunpeng Feng,1– 3 Tianlong Wang,1– 3 Xuexin Feng1– 3 1Department of Anesthesiology, Capital Medical University Xuanwu Hospital, Beijing, People’s Republic of China; 2Center for Sleep and Consciousness Disorders, Capital Medical University, Beijing, People’s Republic of China; 3Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Xuexin Feng, Department of Anesthesiology, Capital Medical University Xuanwu Hospital, No. 45 Changchun St., Xicheng District, Beijing, 100053, People’s Republic of China, Tel +86-1083798277, Email fengxuexin@xwhosp.orgPurpose: Remimazolam is a new type of ultrashort benzodiazepine drug with an unclear optimal dose for general anesthesia induction in elderly patients aged > 60 years. Therefore, this study aimed to determine the effective dose of remimazolam tosilate induction and explore its correlation with the bispectral index (BIS).Patients and Methods: A total of 42 elderly patients were divided into two age groups: 60– 69 (group A) and 70– 85 (group B) years. An initial dose of 0.1mg/kg(Group A) and 0.05 mg/kg(Group B) remimazolam tosilate was administered, and the Modified Observer’s Assessment of Alertness/Sedation scale was used to assess adequate responses. The dose was calculated using the up-and-down allocation technique based on the previous response. The sequential formula and probit regression model were used to calculate ED50 and BIS50. ED95 was determined using the probit regression model.Results: The ED50 of remimazolam tosilate for anesthesia induction were 0.088 mg/kg (95% confidence interval [CI] 0.071– 0.108) and 0.061 mg/kg (95% CI 0.053– 0.069) in groups A and B, respectively. ED95 was 0.118 mg/kg (95% CI 0.103– 0.649) and 0.090 mg/kg (95% CI 0.075– 0.199) in groups A and B, respectively. The remimazolam tosilate administration could decrease BIS. BIS50 was 86.0 (95% CI 83.7– 88.6) and 85.4 (95% CI 84.1– 86.8) in groups A and B, respectively.Conclusion: During the induction process, patients’ consciousness should be observed. The dose of remimazolam tosilate could be chosen after careful consideration of individual variations.Keywords: remimazolam, anesthesia induction, geriatric, up-and-down sequential allocationhttps://www.dovepress.com/the-median-effective-dose-and-bispectral-index-of-remimazolam-tosilate-peer-reviewed-fulltext-article-CIAremimazolamanesthesia inductiongeriatricup-and-down sequential allocation |
| spellingShingle | Liu M Sun Y Zhou L Feng K Tianlong Wang Feng X The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial Clinical Interventions in Aging remimazolam anesthesia induction geriatric up-and-down sequential allocation |
| title | The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial |
| title_full | The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial |
| title_fullStr | The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial |
| title_full_unstemmed | The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial |
| title_short | The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial |
| title_sort | median effective dose and bispectral index of remimazolam tosilate for anesthesia induction in elderly patients an up and down sequential allocation trial |
| topic | remimazolam anesthesia induction geriatric up-and-down sequential allocation |
| url | https://www.dovepress.com/the-median-effective-dose-and-bispectral-index-of-remimazolam-tosilate-peer-reviewed-fulltext-article-CIA |
| work_keys_str_mv | AT lium themedianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT suny themedianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT zhoul themedianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT fengk themedianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT tianlongwang themedianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT fengx themedianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT lium medianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT suny medianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT zhoul medianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT fengk medianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT tianlongwang medianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial AT fengx medianeffectivedoseandbispectralindexofremimazolamtosilateforanesthesiainductioninelderlypatientsanupanddownsequentialallocationtrial |